Tag Archives: Francesca Gay

Sarclisa Combination Therapy Boosts Myeloma Remission Rates in Phase 3 Trial

Posted on 11, December 2023 by

(IN BRIEF) In the Phase 3 IsKia trial presented at the American Society of Hematology (ASH) Annual Meeting, Sarclisa® (isatuximab) combined with carfilzomib, lenalidomide, and dexamethasone (KRd) demonstrated a significant improvement in achieving minimal residual disease (MRD) negativity among newly … Read the full press release →

Posted in Business, Education, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology

Tagged , , , , , , , , , ,